[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  AGORACOM - George [@AGORACOM](/creator/twitter/AGORACOM) on x 15.1K followers Created: 2025-07-15 15:59:24 UTC FDA Submission in Progress for Lucid‑MS Phase X Trial @QuantumBP NASDAQ: QNTM / CSE: QNTM 💡 Lead therapy Lucid‑MS successfully completed Phase X trials — no serious side effects reported ✅ FDA submission now in preparation for Phase X clinical trial approval 🧠 Targets myelin protection and repair — a new approach to Multiple Sclerosis beyond immune suppression ⚕️ Advancing a first-in-class neuroprotective therapy for MS patients  XXXXX engagements  **Related Topics** [nasdaq](/topic/nasdaq) [Post Link](https://x.com/AGORACOM/status/1945151219862753550)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
AGORACOM - George @AGORACOM on x 15.1K followers
Created: 2025-07-15 15:59:24 UTC
FDA Submission in Progress for Lucid‑MS Phase X Trial
@QuantumBP NASDAQ: QNTM / CSE: QNTM
💡 Lead therapy Lucid‑MS successfully completed Phase X trials — no serious side effects reported
✅ FDA submission now in preparation for Phase X clinical trial approval
🧠 Targets myelin protection and repair — a new approach to Multiple Sclerosis beyond immune suppression
⚕️ Advancing a first-in-class neuroprotective therapy for MS patients
XXXXX engagements
Related Topics nasdaq
/post/tweet::1945151219862753550